Provided by Tiger Trade Technology Pte. Ltd.

Chromocell Therapeutics Corp

13.50
0.0000
Volume:- -
Turnover:253.52K
Market Cap:87.55M
PE:-10.88
High:13.50
Open:13.50
Low:13.50
Close:13.50
52wk High:13.50
52wk Low:0.4500
Shares:6.49M
Float Shares:2.51M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2405
EPS(LYR):-1.4271
ROE:-26.00%
ROA:-188.95%
PB:-20.87
PE(LYR):-9.46

Loading ...

Company Profile

Company Name:
Chromocell Therapeutics Corp
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.